$XENE 4 SEC Filings

Filed On	Filing
16 Oct 2026	Form 4: Kelly Thomas Patrick, Chief Financial Officer Received 7,500 shares by exercise or conversion
01 Oct 2026	Form 4: Kelly Thomas Patrick, Chief Financial Officer Bought 15,000 shares ($560K)
01 Oct 2026	Form 4: Mortimer Ian, Director Bought 30,000 shares ($1.12M)
03 Sep 2026	Form 4: Svoronos Dawn, Director Received 5,144 shares by exercise or conversion ($41.9K)
31 Aug 2026	Form 4: Kenney Christopher John, Chief Medical Officer Sold 7,068 shares ($426K)
13 Aug 2026	Form 4: Gannon Steven, Director Sold 10,000 shares ($641K)
08 Jun 2026	Form 4: Patou Gary, Director Sold 1,322 shares ($70.3K)
08 Jun 2026	Form 4: Cannon Gillian, Director Sold 1,190 shares ($63.2K)
03 Jun 2026	Form 4: Patou Gary, Director Received 2,645 shares by exercise or conversion · Granted 10,507 Share Option (Right to Buy) · Granted 1,593 Restricted Share Units
03 Jun 2026	Form 4: Machado Patrick, Director Received 2,645 shares by exercise or conversion · Granted 10,507 Share Option (Right to Buy) · Granted 1,593 Restricted Share Units
03 Jun 2026	Form 4: Gover Justin D., Director Received 2,645 shares by exercise or conversion · Granted 10,507 Share Option (Right to Buy) · Granted 1,593 Restricted Share Units
03 Jun 2026	Form 4: Garofalo Elizabeth A., Director Received 2,645 shares by exercise or conversion · Granted 10,507 Share Option (Right to Buy) · Granted 1,593 Restricted Share Units
03 Jun 2026	Form 4: Gannon Steven, Director Received 2,645 shares by exercise or conversion · Gave up 1,416 shares to cover exercise price or tax ($75.6K) · Granted 10,507 Share Option (Right to Buy) · 1 more
03 Jun 2026	Form 4: Cannon Gillian, Director Received 2,645 shares by exercise or conversion · Granted 10,507 Share Option (Right to Buy) · Granted 1,593 Restricted Share Units
03 Jun 2026	Form 4: Svoronos Dawn, Director Received 2,645 shares by exercise or conversion · Gave up 1,416 shares to cover exercise price or tax ($75.6K) · Granted 10,507 Share Option (Right to Buy) · 1 more
13 May 2026	Form 4: Gannon Steven, Director Received 3,500 shares by exercise or conversion ($25.8K)
13 Mar 2026	Form 4: Kenney Christopher John, Chief Medical Officer Received 3,750 shares by exercise or conversion · Sold 1,410 shares ($77.9K)
13 Mar 2026	Form 4: DiFabio Andrea, Chief Legal Officer Received 3,750 shares by exercise or conversion · Sold 1,342 shares ($74.1K)
13 Mar 2026	Form 4: Mortimer Ian, Director Received 12,500 shares by exercise or conversion · Sold 7,308 shares ($404K)
11 Mar 2026	Form 4: Kenney Christopher John, Chief Medical Officer Received 7,500 shares by exercise or conversion · Granted 7,500 Performance Share Units · Sold 2,771 shares ($167K)

Comments